MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3

• Jufeng Zhang ,

  Contributed equally to this work with: Jufeng Zhang, Yanxin Lu

  * E-mail: jfzhang111@163.com (ZJF); wanj@ust.hk (WJ); kepengwang@gmail.com (WKP)

  Affiliations School of Life Science, Guangdong Pharmaceutical University, Guangzhou, China, Biomedical Research Institute, Shenzhen-PKU-HKUST Medical Center, Shenzhen, China

  ⨯
• Yanxin Lu ,

  Contributed equally to this work with: Jufeng Zhang, Yanxin Lu

  Affiliation Biomedical Research Institute, Shenzhen-PKU-HKUST Medical Center, Shenzhen, China

  ⨯
• Xupeng Yue,

  Affiliation Biomedical Research Institute, Shenzhen-PKU-HKUST Medical Center, Shenzhen, China

  ⨯
• Huiming Li,

  Affiliation Experimental Research Center, First People’s Hospital, School of Medicine, Shanghai Jiaotong University, Xuhui, Shanghai, China

  ⨯
• Xia Luo,

  Affiliation College of Engineering, South China Agricultural University, Guangzhou, China

  ⨯
• Ying Wang,

  Affiliation Biomedical Research Institute, Shenzhen-PKU-HKUST Medical Center, Shenzhen, China

  ⨯
• Kepeng Wang ,

  * E-mail: jfzhang111@163.com (ZJF); wanj@ust.hk (WJ); kepengwang@gmail.com (WKP)

  Affiliation Biomedical Research Institute, Shenzhen-PKU-HKUST Medical Center, Shenzhen, China

  ⨯
• Jun Wan

  * E-mail: jfzhang111@163.com (ZJF); wanj@ust.hk (WJ); kepengwang@gmail.com (WKP)

  Affiliations Biomedical Research Institute, Shenzhen-PKU-HKUST Medical Center, Shenzhen, China, Division of Life Science, Hong Kong University of Science and Technology, Hong Kong, China

  ⨯